O'Brien Greene & Co. Inc Bristol Myers Squibb CO Transaction History
O'Brien Greene & Co. Inc
- $305 Million
- Q3 2024
A detailed history of O'Brien Greene & Co. Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 6,048 shares of BMY stock, worth $348,243. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,048
Previous 6,304
4.06%
Holding current value
$348,243
Previous $261,000
19.54%
% of portfolio
0.1%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.14 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.35 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.49 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.51 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...